Background. This review tackles the question : ' Is bereavement related depression (BRD) the same or different from standard (non-bereavement-related ) major depression (SMD)? ' To answer this question, we examined published data on key characteristics that define and characterize SMD to assess whether they also characterize BRD.
INTRODUCTION
Specific external causes very frequently seem to foster the outbreak of melancholia. Some such causes, which can be cited, are physical diseases (influenza, gastritis), operations, losses of fortunes, shock, worries due to business ventures, changes in living conditions, but above all, illness and death of the next of kin. (Kraepelin, 1899 (Kraepelin, /1990 Is depression a normal reaction to the death of a loved one ? This question, the focus of this review, remains a source of ongoing controversy. We pose the question as :
Is bereavement-related depression (BRD) the same or different from standard (non-bereavement-related ) major depression (SMD) ?
Since Kraepelin's observation of the importance of bereavement in the pathogenesis of major depressive disorder (MDD), several investigators have provided empirical confirmation. In the Epidemiological Catchment Area Study of Mental Disorders in the United States, for example, Weisman et al. (1991) found that 10 % of all community-dwelling individuals experienced the onset of their depressive syndromes within 1 year of the death of a loved one. These individuals, however, were not diagnosed with MDD because of their bereaved status. Karam (1994) found that 26 % of adults in Lebanon who otherwise met criteria for MDD had experienced the death of a loved one within 2 months of the diagnosis. More recently, Cole & Dendukuri (2003) , providing a systematic review and meta-analysis of 20 prospective studies on late-life MDD, found that recent bereavement was the most robust risk factor for the onset of a major depressive episode (MDE). Several studies focusing on bereaved populations have found depressive symptoms, subsyndromal depressive syndromes, minor depression (Zisook et al. 1994 (Zisook et al. , 1997 , and major depressive syndromes (Clayton et al. 1972 ; Jacobs et al. 1989 ; Bruce et al. 1990 ; Nuss & Zubenko, 1992 ; Zisook et al. 1994 ; Carnelley et al. 1999 ; Turvey et al. 1999 ; Byrne & Raphael, 1999 ; Silverman et al. 2001 ; Barry et al. 2002 ; Onrust & Cuijpers, 2006) highly prevalent and often persistent. Major depressive syndromes have been reported in 29-58% of widows and widowers 1 month after their spouse's death (Clayton et al. 1972; Gilewski et al. 1991 ; Harlow et al. 1991b) , 20-25 % at 2 months (Futterman et al. 1990 ; and 4 months (Clayton et al. 1972 ; McHorney & Mor, 1988) , 16-17 % at 1 year (Clayton et al. 1972 ; Bornstein et al. 1973 ; Zisook & Shuchter, 1991 b) , and 14-16 % at 2 years (Harlow et al. 1991b ; . Similar rates have been found in children (Weller et al. 1991) and in older adults Turvey et al. 1999) after the deaths of loved ones.
Despite the well-documented association of bereavement and MDD, BRD historically has been under-recognized and under-treated (Rosenzweig et al. 1997) . Even today, confusion remains regarding how to distinguish depression form chronic or complicated grief (Lichtenthal et al. 2004) , and when and how to diagnosis or treat BRD. By evaluating the similarities and differences between BRD and SMD on risk factors, clinical characteristics, course, consequences, biology and treatment, we attempt to clarify this confusion. When the data permits, we pay particular attention to depressive syndromes occurring within the first 2 months of bereavement. This is the time period the DSM-TR (APA, 2000) delineates for bereavement to exclude the diagnosis of MDD.
If BRD is no different than SMD -and especially if BRD occurring within the first few months of the death of a loved one is no different than SMD -the bereavement exclusion for MDE may be invalid.
Brief historical background
Contemporary views of the relationship between loss, grief and depression have their roots in Freudian psychoanalytic theory which holds that grief and depression share many features (Freud, 1957) . Lending empirical credence to this concept, a series of studies by Paula Clayton and colleagues a decade before DSM-III documented the high prevalence of major depressive syndromes occurring during bereavement. Thirty-five percent of widows and widowers met criteria for clinical depression 1 month after their spouse's death, and one third of those remained depressed for at least a year. Because these depressive syndromes tended to be relatively mild and 'differed ' from clinical depression in several ways, Clayton cautioned against over-diagnosing major depression during the first year of bereavement (Clayton et al. 1971 (Clayton et al. , 1972 Bornstein et al. 1973 ; Clayton, 1974 ; Clayton & Darvish, 1979) . Clayton et al.'s findings and conclusions served as the forerunners to the DSM-III exclusion of bereavement for the diagnosis of MDE.
DSM-III and DSM-III-R
In DSM-III, 'Uncomplicated Bereavement' was both a V-Code (clinical condition that is not a mental disorder) and an exclusion criterion for the diagnosis of MDE. According to DSM-III, 'Uncomplicated Bereavement':
can be used when a focus of attention or treatment is a normal reaction to the death of a loved one. A full depressive syndrome is a normal reaction to such a loss, with feelings of depression and such associated symptoms as poor appetite, weight loss and insomnia. The reaction to the loss may not be immediate, but rarely occurs after the first two or three months. The duration of 'normal ' bereavement varies considerably among different subcultural groups (APA, 1980, p. 333) .
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S. Zisook and K. S. Kendler To help distinguish 'Uncomplicated Bereavement ' from MDE, DSM-III identified features more characteristic of one than the other : (1) a bereaved individual typically regards the depressed mood as 'normal,' although the person may seek professional help for relief of associated symptoms such as insomnia or anorexia; (2) the diagnosis of MDE is generally not given unless the symptoms are still present 2-3 months after the loss ; and (3) MDE should be considered in the presence of certain symptoms that are not characteristic of a 'normal ' grief reaction, such as guilt about things other than actions taken or not taken by the survivor at the time of the death, thoughts of death other than the survivor feeling that he or she would be better off dead or should have died with the deceased person, morbid preoccupation with worthlessness, marked psychomotor retardation, prolonged and marked functional impairment, and hallucinatory experiences other than thinking that he or she hears the voice of, or transiently sees the image of, the deceased person. Thus, the category of 'Uncomplicated Bereavement ' assumed that a full MDE beginning in the first few months after the loss of a loved one and lasting an indeterminate period of time is normal.
DSM-IV and DSM-TR
In DSM-IV, 'Uncomplicated Bereavement' was replaced by ' Bereavement '. Other than more sharply delineating the time frame for 'Bereavement ' to be 2 months (rather than 2-3 months), there were no substantive changes in diagnostic guidelines. Bereavement remains the only life event that excludes the diagnosis of MDE.
Terminology
Before beginning our literature review, we clarify critical terms. Mourning refers to the social and culturally sanctioned rituals related to loss. Grief refers to the constellation of feelings, behaviors, cognitions and alterations in functioning attendant upon loss of any kind. Bereavement is a specific type of loss, loss from another's death. Bereavement reactions refer specifically to grief following the death of a significant other. The DSM-IV added a second definition for bereavement -symptoms of MDE occurring within the first few months of the death of a loved one.
The terms -mourning, grief and bereavement -are often used interchangeably, resulting in confusion. To make matters more complicated, several terms are used to describe perturbation in grief (e.g. pathological, morbid, atypical, dysfunctional, unresolved) . Recently, much attention has been paid to a syndrome of unusually intense and persistent grief, so-called complicated or traumatic grief (Horowitz et al. 1997; Prigerson et al. 1997 ; Shear et al. 2005) . Characterized by symptoms of persistent difficulty accepting the death, recurrent pangs of intense grief, preoccupation with thoughts and images of the deceased, and avoidance of reminders of the loss, complicated grief is a different construct than MDD and can reliably be distinguished from it (Prigerson et al. 1996 ; Boelen & van den Bout, 2005) . The focus of this review is not complicated grief, per se, but rather BRD.
As used in this review, BRD refers to three potentially different groups that are important to distinguish conceptually : (1) individuals who develop symptoms meeting criteria for MDE in the context of the death of a loved one ; it often is not specified whether the MDE began shortly before, shortly after, or months after bereavement ; (2) individuals who, within 2 months after the loss of a loved one, develop symptoms that technically meet the broad heterogeneous criteria for MDE (i.e. at least 5 out of 9 symptoms lasting at least 2 weeks) but who are considered by the DSM-TR to be experiencing 'normal bereavement ' ; and (3) individuals who, after the loss of a loved one, also develop symptoms that meet criteria for MDE but whose symptoms are so severe or persistent that the DSM-TR recommends considering the diagnosis of a true MDE rather than just normal bereavement. As we will try to point out, most of the available literature on BRD focuses on Group 1, and therefore can provide only indirect data on the DSM exclusion. There is even less data on Group 3. Wherever possible, this review will highlight results on Group 2, the most pertinent group for the bereavement exclusion criteria.
Summary
In order to answer the question of whether BRD is the same or different from SMD, this review will evaluate whether key characteristics that define and characterize SMD also characterize BRD. If the predominate weight of the evidence suggests that they do, BRD may be best conceptualized as a form of SMD rather than an extension of 'normal ' bereavement.
METHOD Empirical literature review
Using diagnostic validators as originally proposed by Robins & Guze (1970) and expanded by Kendler (1980) For each study, we present our qualitative assessment of the degree to which it supports or refutes our null hypothesis. This judgment reflects the nature of the finding and the study's methodological rigor, appropriateness of comparison group, and sample size.
If the same sample was presented in more than one publication, only the most relevant or inclusive is examined. The lone exception to this rule is in the categories of family and past history studies where two different studies from Paula Clayton's series of widowhood studies are tabulated because different control groups were used (Clayton et al. 1971 ; Briscoe & Smith, 1975) .
For most validating criteria, the ideal comparison group for BRD would be a matched group of SMD. However, few studies compared these two groups directly. Therefore, in the seven Appendix tables we prepared for this review, termed Tables A1-A7 (available in the online version of this paper or at http:// geropsych.ucsd.edu/grief), we provide a complete study summary and a categorization of the different comparison groups, which include : (A) comparison of BRD and SMD, (B) comparison of bereaved individuals with nonbereaved controls, (C) comparison of BRD with uncomplicated bereavement, (D) comparison of bereaved individuals to in-patient SMD, (E) study of BRD only, and (F) study of bereaved individuals only.
While it would have been ideal to conduct formal meta-analyses of this literature, this was not feasible. Few primary reports provided confidence intervals (or standard errors) or primary data (i.e. contingency tables or correlations). Data is presented so as to facilitate an integration of results comparing the validators in the groups. Table 2 summarizes the overall results. For each group of validators, a global score is provided summarizing its overall support for the study's hypothesis (I=equivocal ; S=supportive ; NS=not supportive).
RESULTS

Antecedent validators
Family and past personal history of major depression Two of the most consistently noted predictors of SMD are family history (Weissman et al. 2005) , and past personal history of SMD (Lewinsohn et al. 1988) . Tables 1 and A1 describe nine studies assessing the relationships of family and/or past history of SMD and the onset of major depression in recently bereaved individuals. Three of the studies included an SMD control group, but the number of control participants with MDE in each of these studies was small (Briscoe & Smith, 1975; Brent et al. 1994; . A fourth study included a non-bereaved control group, but since none of the controls had MDE, only comparisons between bereaved individuals with and without MDE are considered (Byrne & Raphael, 1999) . Another study (Briscoe & Smith, 1975 ) included a non-bereaved control group, divorced men and women, as well as in-patients with SMD, and compared both groups to widows and widows previously reported by Clayton and colleagues (Clayton et al. 1971 (Clayton et al. , 1972 Bornstein et al. 1973 ; Clayton, 1974 ; Clayton & Darvish, 1979) . However, in-patients with SMD are a questionable comparison group since BRD rarely requires hospitalization. Similarly, one study compared bereaved children to in-patient children with MDD (Weller et al. 1991) . The remaining three studies primarily compared bereaved individuals with BRD to bereaved individuals without depression (Clayton et al. 1971 ; Jacobs et al. 1989; Zisook & Shuchter, 1993 b) .
Of the six studies evaluating family history of depression among those who were bereaved (Tables 1 and A1) , three found family history of MDE to be positively associated with BRD (Weller et al. 1991; Brent et al. 1993 ; Zisook & Shuchter, 1993 b) . One of the negative studies looked at family history of mood disorder rather than specifically depression (Clayton, 1974) . However, in a separate investigation, the 18 widows and four widowers who met syndromal criteria for SMD from Clayton et al.'s study (Clayton et al. 1972 ; Clayton, 1974) were compared to 22 age-and sex-matched hospitalized depressives and 43 recently divorced men and women meeting the same diagnostic criteria for syndromal depression (Briscoe & Smith, 1975) . Compared to both the hospitalized patients and the divorced depressives, the depressed widows/widowers had fewer first-degree relatives with MDD. This is the only study we found that compared syndromal depression in bereaved individuals to SMD occurring in the context of other adverse life events, but the sample was small and the two groups were poorly matched for age. Tables 1 and A1 also contain the nine studies examining the relationship of past history of 'depression ' and risk for BRD in bereaved individuals. The findings are mixed. One study used past treatment for SMD rather than occurrence of SMD (Clayton et al. 1971) , and three assessed dysphoria rather than syndromal SMD (Bruce et al. 1990 ; Hays et al. 1994a ; Byrne & Raphael, 1997) . Three of the studies that assessed past histories of actual SMD found positive relationships between past SMD and BRD (Weller et al. 1991; Brent et al. 1993 ; Zisook et al. 1997) . One of the studies not only found a relationship between past histories of SMD and BRD, but also reported a significant gradation in risk based on the number of previous MDEs : the rates of BRD at 6-8 weeks post-bereavement for widows and widowers who had never been depressed was 13 %, for those who had been depressed once previously was 30 %, and for those who had experienced two or more pre-bereavement MDEs was 46 % (Zisook et al. 1997) . On the other hand, one study found fewer episodes of previous SMD in widows and widows with BRD than in comparable groups of in-patients or divorcees with SMD (Briscoe & Smith, 1975) .
Demographic factors
The demographic factors most strongly associated with risk for SMD are female gender and young adult age (Kessler et al. 2005) . Tables 1  and A2 summarizes studies evaluating the associations of these factors with onset of BRD : two studies compared BRD to SMD (McHorney & Mor, 1988; Karam, 1994) , two compared bereaved with non-bereaved groups (Gallagher et al. 1983 ; Lichtenstein et al. 1996) , five compare bereaved with BRD to bereaved who were not depressed (Clayton et al. 1971 ; Richards & McCallum, 1979 ; McHorney & Mor, 1988 ; Jacobs et al. 1989; Zisook & Shuchter, 1993a) and one compared widows and widowers on a depression intensity scale (Lund et al. 1986) .
Four of eight studies comparing men and women found no gender difference in risk for BRD (Clayton et al. 1971 ; Lund et al. 1986 ; McHorney & Mor, 1988 ; Zisook & Shuchter, 1993a) while three of the remaining four studies reported that women were more likely than men to experience BRD (Gallagher et al. 1983 ; Jacobs et al. 1989 ; Bruce et al. 1990) . One small study reported men to be at greater risk (Richards & McCallum, 1979) . Another large study of older adults (not included in Table A2 because it did not provide statistical comparisons between men and women), found women to have more depression than men shortly pre-bereavement (26 % v. 15%), while men had more depression during the first year of bereavement (46 % v. 32 %) (Mendes De Leon et al. 1994) . Results of studies examining the association of age with BRD were also mixed. Five of six studies reported increased rates of BRD in younger individuals (Gallagher et al. 1983 ; McHorney & Mor, 1988 ; Jacobs et al. 1989 ; Bruce et al. 1990 ; Lichtenstein et al. 1996) , while one study reported no difference (Bruce et al. 1990 ). Performing a house-to-house survey in Lebanon, Karam (1994) found no differences in the age of onset of 94 individuals with BRD and 281 non-bereaved individuals with SMD.
Antecedent validators in subjects within 2 months of bereavement To address as directly as possible the validity of the bereavement exclusion for the diagnosis of MDD, it is important to evaluate bereaved individuals who meet symptomatic criteria for MDE within 2 months of the death of a loved one but who are considered by the DSM-TR to be experiencing 'normal bereavement '. Of the two studies that evaluated family history and past personal history of MDE, one supported the major hypothesis we are evaluating -that BRD resembles SMD (Zisook et al. 1997 ) -and one did not (Clayton et al. 1972) . One of four studies that evaluated gender supported this hypothesis (Gallagher et al. 1983 ) and three did not (Clayton et al. 1971 ; Lund et al. 1986; Zisook et al. 1997) . In contrast, each of the three studies that evaluated age or age of onset provided support for the hypothesis that SMD closely resembles SMD (Gallagher et al. 1983 ; Karam, 1994) . Overall, then, it does not appear that the antecedent validators of family and past personal histories of MDD or gender or age provide consistent evidence for or against the close similarity between BRD and SMD.
Concurrent validators
A number of environmental, clinical and biological features characterize SMD. Two important concurrent risk factors for SMD are poor physical health (Barkow et al. 2002) and low social support (Kendler, 1999) . Some of the clinical features that are associated with SMD are characteristic symptoms (Gaynes et al. 2005) , dysfunction and disability (Judd et al. 2000) , and suicidality (Sokero et al. 2005) . Biological factors that often are seen in SMD include adrenocortical dysregulation (Nemeroff, 1998) , immune dysfunction (Dunn et al. 2005) and sleep architecture disruption (Reynolds & Kupfer, 1987) . Tables 1 and A3 summarize seven studies presenting data on physical health and/or social supports and the subsequent onset of BRD. None of these studies compared BRD to SMD. One of the studies compared bereaved to matched non-bereaved individuals (Norris & Murrell, 1990) , three compared bereaved persons with BRD to those without depression (Clayton, 1975; McHorney & Mor, 1988; Zisook & Shuchter, 1991 b) and three examined bereaved populations without comparison groups (Dimond et al. 1987 ; Nuss & Zubenko, 1992) . All three studies assessing health and/or physical limitations found significant relationships between poor health and onset of BRD (Clayton, 1975; McHorney & Mor, 1988; . Five of six studies measuring social support found an inverse relationship between social supports and BRD (Clayton, 1975; Dimond et al. 1987 ; Norris & Murrell, 1990; Nuss & Zubenko, 1992) .
Health and social support
Associated clinical features
Clinical features associated with BRD are summarized in Tables 1 and A4 . In the only two studies that compared adults with BRD and SMD (Bruce et al. 1990 ; Karam, 1994) , more similarities than differences were noted between the two groups. Comparing newly bereaved men and women with prospectively defined BRD to married men and women with SMD, Bruce et al. (1990) reported similar rates of psychomotor changes and suicidal ideation, but lower rates of guilt and worthlessness in those with BRD. Karam (1994) reported that the two syndromes were indistinguishable in terms of duration of episodes, degree of dysfunction, and helpseeking behaviors. In a study of adolescent bereavement, Brent et al. (1993) , also included a control group of non-bereaved adolescents, but there were too few with SMD to provide meaningful comparisons with bereaved adolescents who had BRD. However, that study did report that the 43 adolescents with BRD had high rates of several features known to characterize SMD : co-morbid PTSD, impaired functioning and suicidality.
Since psychomotor retardation, feelings of worthlessness and suicidal ideation are symptoms purported to discriminate between normal bereavement and bereavement complicated by major depression in the DSM-III, -III-R, -IV and -TR, studies that describe the presence or severity of those symptoms in BRD are included. In addition to the two studies described in the preceding paragraph (Bruce et al. 1990; Karam, 1994) , five other relevant reports were found. Bornstein et al. (1973) reported over a third of recently bereaved widows and widowers who met syndromal criteria for BRD felt 'worthless and no good ', 56 had death wishes and 7 % expressed suicidal ideation. Suicidal ideation and feelings of worthlessness were two of the few depressive symptoms that did not decrease over the first year of widowhood (Bornstein et al. 1973) . Jacobs et al. (1989) found that BRD at 6 and 12 months were associated with anxiety, psychomotor retardation and other melancholic features. reported significantly higher rates of feelings of worthlessness and thoughts of ending one's life among widows and widowers with BRD compared to those without BRD or married controls. In a study of older widowers, Byrne & Raphael (1999) reported high rates of psychomotor disturbance, feelings of worthlessness and suicidal ideation among widowers with BRD versus non-depressed widowers.
Studying 38 prepubertal children who experienced death of a parent and 38 matched inpatient depressed control children, Weller et al. (1991) reported the most frequent symptoms experienced by all of the bereaved children were : dysphoria (61 %), suicidal ideation (61 %), loss of interest (45 %), psychomotor agitation or retardation (37 %), guilt/worthlessness (37 %). The occurrence of individual depressive symptoms was reported less frequently by the recently bereaved children than by in-patient depressed children but the overall pattern of symptoms was similar. Unfortunately, no comparisons were made between the depressed in-patient children and the subgroup of bereaved children who met symptom criteria for major depression to see how symptoms in these two groups compared.
Biological factors
Developments in bereavement biology have occurred on three major fronts: endocrinologic responses, immunologic changes and physiologic studies. Each of these domains could serve as external validators to evaluate our key hypothesis.
SMD has been associated with several perturbations in various biological systems. For example, endocrinologic studies have demonstrated adrenocortical dysregulation and overactivation in patients with SMD (Carroll et al. 1981; Lesch et al. 1988) . Impaired immune function also has been identified an important feature of SMD (Schleifer et al. 1984) . One of the most consistent findings found in patients with SMD has been alterations in sleep architecture (e.g. decreased rapid eye movement latency and deep sleep duration) (Kupfer et al. 1991) . More recently heart rate variability, an important mediator of health and disease, has been found to be decreased in SMD (Rechlin et al. 1994) . The studies, highlighted in Tables 1  and A5 , include : two studies comparing subjects with BRD to those with SMD (Roy et al. 1988 ; Reynolds et al. 1992) , one study comparing bereaved individuals to depressed and nonbereaved controls (O'Connor et al. 2002) , four studies comparing bereaved to matched nonbereaved samples (Linn et al. 1984 ; Irwin et al. 1987 ; Gerra et al. 2003) , and three studies evaluating bereaved elderly adults (Kosten et al. 1984) , adults Weller et al. 1990 ) and children that did not include control groups.
Four of the studies summarized in Tables 1  and A5 assessed the dexamethasone suppression test (DST) in bereaved individuals. Rates of non-suppression were 0% (Kosten et al. 1984) , 16 % (Shuchter, 1986) , and 36 % (Weller et al. 1990) in the three relevant studies. The fourth study reported blunted mean cortisol levels in bereaved versus non-bereaved groups (Gerra et al. 2003) . In two of the studies, cortisol levels (Kosten et al. 1984) or abnormal DSTs (Gerra et al. 2003) were directly related to severity of depression. None of these studies assessed depressed controls. In contrast, one small study measuring adrenocorticotropin (ACTH) response to corticotrophin-releasing hormone (CRH) did employ a depressed control group and reported that subjects with BRD demonstrated ACTH responses to CRH similar to those with SMD, and distinct from bereaved individuals without BRD and normal controls (Roy et al. 1988) .
Four studies assessed immune function in patients with BRD. Three of the studies found impaired immune function related to depression symptom severity (Linn et al. 1984 ; Irwin et al. 1987 ; Gerra et al. 2003 ) and the fourth found abnormal immune function only in the subset of bereaved individuals with BRD .
Two studies assessed physiologic measures in BRD and both included controls with SMD. In the first, sleep patterns were measured in patients with BRD, depressed controls and normal controls ; only the subgroup of bereaved subjects with BRD had abnormal sleep architecture. Their sleep resembled individuals with recurrent MDD and differed from other bereaved individuals without BRD (Reynolds et al. 1992 ). In the second study, heart rate variability (HRV) was decreased in bereaved individuals in direct relationship to levels of depression.
Concurrent validators in subjects within 2 months of bereavement In subjects within 2 months of bereavement, BRD was associated with poor health Zisook & Shuchter, 1991 b) and social support (Clayton et al. 1975 ; Dimond et al. 1987; . In addition, compared to bereaved individuals without BRD within 2 months of the loss, those with BRD had more suicidal thoughts, feelings of worthlessness and psychomotor disturbances (Clayton & Darvish, 1979 ; Bruce et al. 1990 ; Byrne & Raphael, 1999) , though not so in comparison to hospitalized patients with SMD (Weller et al. 1991) . Thus, symptoms that the DSM specifically states should raise consideration for the diagnosis of MDD, even in the face of recent bereavement, often characterize the depressive syndromes of recently bereaved individuals. In this way, BRD may resemble SMD more than it resembles 'uncomplicated bereavement '. Similarly, the four studies that evaluated biological parameters within the first 2 months of bereavement mostly supported the similarity of BRD with SMD. Two found immunologic changes in bereaved adults to resemble these reported in SMD (Zisook et al. 1994 ; Gerra et al. 2003) . One study in adults with BRD (Gerra et al. 2003) and another in children with BRD (Weller et al. 1991) found DST non-suppression in recently bereaved individuals to correlate with depression symptom severity while one study found DST nonsuppression more associated with anxiety than with depressive symptoms in recently bereaved widows and widowers ). Tables 1 and A6 summarize studies examining the persistence over time of BRD. Table A6 is divided into three sections. First are two studies directly assessing whether BRD predicts future SMD. Studying an adult community population 788 S. Zisook and K. S. Kendler in Lebanon, Karam (1994) found that BRD was as likely as SMD to predict future SMD. In a study of adolescents losing a close friend to suicide, Brent et al. (1994) also reported that BRD predicts future SMD. Like Karam (1994) , Brent et al. (1994) also reported that the mean durations of BRD were similar to those reported for SMD. Tables 1 and A6 also summarize ten studies that evaluated bereaved individuals both before and after the deaths of loved ones. Those studies found uniformly higher rates of depressive syndromes than in non-bereaved controls lasting well beyond the first several months after bereavement. Several of those studies reported that symptoms of depression often began months to years before the actual death (Norris & Murrell, 1990 ; Harlow et al. 1991 b; Lichtenstein et al. 1996 ; Carnelley et al. 1999) . It is not clear to what extent the 'persistence ' of BRD in these studies represents recurrent versus chronic depression. In either case, BRD is often not a transient phenomenon.
Predictive validators Diagnostic consistency over time
The third set of studies comprises five longitudinal assessments of widows and widowers with and without BRD following spousal bereavement. These studies report high rates of depressive syndromes extending well beyond the first several months of bereavement. Overall, compared to non-bereaved controls, elevated rates of depression may last as long as 6 months (Bruce et al. 1990; Thompson et al. 1991) , 9 months (Norris & Murrell, 1990) , 18 months (Brent et al. 1994) , 2 years (Harlow et al. 1991 b; Stroebe & Stroebe, 1991 ; Hays et al. 1994 a, b; Carnelley et al. 1999; Turvey et al. 1999) , 30 months , or even as long as 3 or more years (Bodnar & Kiecolt-Glaser, 1994; Mendes De Leon et al. 1994 ; Lichtenstein et al. 1996; Wilcox et al. 2003) . Thus, depressive symptoms whose onset occurs within the post-bereavement window of time the DSM uses to exclude the diagnosis of MDE appears to be as chronic and/or recurrent as SMD.
Response to treatment Also shown in Tables 1 and A7 are four open drug trials treating BRD (Jacobs et al. 1987; Pasternak et al. 1991 ; Zisook et al. 2001 a, b; Oakley et al. 2002) and one placebo-controlled study, which included an arm of interpersonal psychotherapy (IPT) (Reynolds et al. 1999) . All showed an effectiveness of antidepressants similar to response rates found in trials of SMD (AJP, 2000) . In the only controlled study Reynolds et al. (1999) reported the highest rates of remission in the group receiving a combination of antidepressant medication and psychotherapy, closely mirroring that group's findings in similarly aged, non-bereaved cases with SMD.
Predictive validators in subjects within 2 months of bereavement Each of the studies that assessed BRD at or within 2 months of bereavement found that BRD tends to persist over time (Clayton & Darvish, 1979 ; Lund et al. 1985 ; Harlow et al. 1991b ; Thompson et al. 1991 ; Hays et al. 1994b ; Karam, 1994 ; Zisook et al. 1997; Turvey et al. 1999) , much like SMD. The only treatment study of individuals who the DSM would diagnose with 'bereavement' rather than MDD based on time since death also found BRD to respond to antidepressant medication similar to other studies of SMD (Zisook et al. 2001 b) .
DISCUSSION
This paper has reviewed data bearing on the similarities and differences between BRD and SMD. Studies assessing antecedent, concurrent and predictive validators were reviewed. Although none of the studies reviewed were designed specifically to examine whether BRD and SMD are different forms of the same disorder, the data presented do address this important question. We attempted to organize the available information to evaluate the following hypothesis : BRD will resemble typical cases of SMD and therefore should be considered a form of SMD. Table 2 summarizes the results of this empirical literature review from this perspective.
As might be expected given a range of methodological differences across the studies as well as the heterogeneity of MDD, results were not entirely consistent. However, a clear trend is noteworthy. The hypothesis receives considerably empirical support. From the perspective of multiple validators, BRD appears to be closely related to SMD. Like SMD, BRD is particularly frequent in bereaved individuals who are young, have past personal or family histories of SMD, and have poor social supports and compromised health. In addition, BRD has clinical characteristics reminiscent of SMD, including : impaired psychosocial functioning; co-morbidity with a number of anxiety disorders ; and symptoms of worthlessness, psychomotor changes and suicidality. Moreover, symptoms of worthlessness, psychomotor changes and suicidality, mentioned in the DSM-TR as unlikely to occur in normal bereavement, can be long lasting and do not predict which individuals with BRD develop chronic or recurrent depression. BRD also has biological characteristics that reflect similarities with SMD : increased adrenocortical activity, impaired immune function and disrupted sleep architecture. Like SMD, BRD is common, long lasting and recurrent. Finally, BRD responds to antidepressant medication.
One can argue that BRD is not the same as SMD in that is often is mild, may remit spontaneously, is not self-perceived as an illness, and shares many symptoms in common with uncomplicated bereavement. But those features often characterize community samples of depressed individuals, as well (Brown et al. 1977 ; Solomon et al. 1997; Judd et al. 1999) . The diagnosis of MDE may be difficult to make, especially soon after the death, as many symptoms of normal grief overlap with those of MDE. Nevertheless, such diagnostic challenges also are present in other instances of MDE.
We also tried to address, wherever the data allowed, whether the current bereavement exclusion for the diagnosis of MDD is consistent with empirical evidence. The 'bereavement exclusion ' was instituted to prevent clinicians from diagnosing MDE when the individual was experiencing a ' normal ' grief reaction. Recognizing that true MDEs could be triggered by the loss of a loved one, guidelines were proposed allowing a MDE to be diagnosed following the loss of a loved one if the duration exceeded 2 months and/or specific symptoms characteristic of a true MDE were present, particularly suicidal ideation, morbid preoccupation with worthlessness, and psychomotor retardation. Thus, the ideal study to test the validity of the bereavement exclusion would compare individuals with : (a) depressive syndromes beginning within 2 months of the loss of a loved one who do not have any of the above-mentioned symptoms with (b) MDEs of similar duration and symptom profile whose onset is unrelated to the death of a loved one. Unfortunately, we found no such studies in the literature.
Since the literature in this area is inconclusive, more research to address the validity of this important exclusion is necessary. If it is true that BRD is no different than SMD -and especially if BRD occurring within the first few months of the death of a loved one is no different than SMD -the bereavement exclusion for MDE may be invalid. This would in turn suggest that cases of MDD occurring after the loss of a loved one may be inappropriately dismissed as ' normal ' grief reactions and therefore not treated. If the opposite is true, i.e. that the exclusion of MDD in the context of bereavement is valid, it raises questions about whether depression occurring after other losses (e.g. divorce, health, financial setbacks) are in need of diagnosis or treatment.
The DSM-IV-TR singles out bereavement as the only stressful life event that excludes the diagnosis of MDE when all other features are present. All substantial stressors, including the death of a loved, increase the risk for onset of a MDE (Brown et al. 1977 ; Lloyd, 1980; Kessler, 1997 ; Kendler et al. 2000) . Kendler et al. (1995) has reported high rates of the onset of MDE following the death of a close relative (OR 16 . 0), and comparably high rates for several other stressful life events, such assault (OR 15 . 0), serious marital problems (OR 12 . 3) and divorce/ break-up (OR 12 . 3). But in none of these cases, other than death of a loved one, does the presence of the stressor negate the diagnosis of MDE. If someone has met the criteria for MDE for more than 2 weeks shortly after they have been assaulted, divorced or suffered a myocardial infarct, we do not say they are not depressed and consider their reaction 'normal. ' Rather, we make the diagnosis of MDE and consider the most appropriate treatment options (Popkin et al. 1985 ; Glassman et al. 2002) .
Several caveats are important to note. First, the majority of studies reviewed here dealt with widowhood and include a preponderance of mid-life and older participants. Two of the studies involved children (losing parents) and adolescents (losing friends to suicide). More data on individuals throughout the lifespan and including a broader spectrum of types of bereavement would increase confidence in the generalizability of conclusions. Second, the primary source of studies included in this review was a Medline search followed by searching the bibliographies of identified manuscripts. Abstracts, posters, reviews and non-data-based chapters were not included. This method may not have captured all relevant articles. Third, some subjectivity may have influenced which studies were included and how some of the data may have been interpreted. Few of the available studies used structured interviews, and even fewer incorporated the most appropriate control groups to answer our key question. Finally, few studies used control groups ideally suited to test our hypothesis. With these caveats in mind, our conclusions must be interpreted with caution.
In summary, this review evaluated studies that bear on the similarities and differences between BRD and SMD. Although the definitive study has yet to be completed, the preponderance of available data supports the hypothesis that BRD resembles typical cases of SMD, and therefore, should be considered instances of SMD. The review also provides some support, although indirect and limited, that excluding recently bereaved individuals from the diagnosis of MDE, when all other symptomatic, duration and functional impairment criteria for MDE are met, may not be justified. BRD, as conceptualized in this review, is likely a mixture of cases including : those defined as 'Bereavement' by the DSM-IV ; those that start out as DSM-IV 'Bereavement' and evolve into true MDEs ; and others whose onset may precede the actual death of a loved one or be delayed for several months after the death. Although this review suggests that bereavement-associated depressive syndromes are probably similar to more typical depressions, the definitive work clarifying the relationship between 'normal grief ' and MDE remains to be done. Given the highly heterogeneous nature of both BRD and SMD, the most propitious conclusion may be that, on average, these two syndromes appear to be closely related. Neither is a true 'natural kind ', but with the rough kind of syndromal data available, these categories appear to be both examples of the same broad syndrome.
